Palatin Technologies, Inc. (PTN)
AMEX·Healthcare·Biotechnology
$11.58
-3.66%
Mkt Cap $291.52M
Analyst Ratings
No recent rating data.
Price Target (3 analysts)
$47.50
Range $47.50 – $47.50
Implied Upside
+310.2%
Consensus $47.50 vs current $11.58
AMEX·Healthcare·Biotechnology
$11.58
-3.66%
Mkt Cap $291.52M
No recent rating data.
Price Target (3 analysts)
$47.50
Range $47.50 – $47.50
+310.2%
Consensus $47.50 vs current $11.58